SymptoLab
PrivateCompany Overview
SymptoLab is a digital health company that provides an AI-powered clinical decision-support platform to help physicians and patients manage complex, hormone-driven conditions.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Healthcare Analytics, Precision Medicine, Vertical SaaS
Business Model
B2B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SymptoLab Comparables
Compare SymptoLab with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dama Health | 78% | |
| FertilAI | 77% | |
| Syrona Health | 71% |
SymptoLab Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2025
Grew 200% QoQ, from 2 to 6 employees.
SymptoLab Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SymptoLab's valuation, stock price, and market status.
Is SymptoLab a public or private company?
SymptoLab is a private company.
What is the current stock price of SymptoLab?
SymptoLab is a private company with no public stock price. No recent secondary market data is available.
How much is SymptoLab worth (valuation)?
Valuation information for SymptoLab is not publicly available.
Can I buy SymptoLab stock?
SymptoLab shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SymptoLab's last funding round?
Funding round information for SymptoLab is not publicly available.
Who are the main investors in SymptoLab?
Investor information for SymptoLab is not publicly disclosed.
Will SymptoLab IPO soon?
No public IPO plans have been announced for SymptoLab.
How can I track SymptoLab secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SymptoLab's secondary market activity and sign up for updates.